Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...

enabled by technologies including chimeric antigen receptor T-cells (CAR T), T-cell receptor therapies (TCR T) and CAR T ...

The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).

Researchers, including those from the Indian Institute of Technology-Bombay and Tata Memorial Hospital, Mumbai, said in low ...

The batteries will be recyclable, in keeping with the Embleme’s philosophy – half of the concept’s materials are recycled and the carbon footprint of its components reduced by 70 per cent. This is an ...

Recruitment of Second Patient for HG-CT-1 Clinical Trial LONDON, GB / ACCESS Newswire / March 17, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce the recruitment of the second p ...

A Toowoomba resident came face-to-face with a redicivist criminal who has spent a majority of his adult life serving jail ...

Royal Bank of Canada reaffirmed their outperform rating on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a ...

Investment analysts at William Blair dropped their Q1 2025 EPS estimates for shares of CARGO Therapeutics in a research note issued to investors on Thursday, March 13th. William Blair analyst S.

The crown jewel of El Salvador’s aggressive anti-crime strategy is a mega-prison where visitation, recreation and education ...

Because the GLC is their best-selling model, Mercedes is changing its electric strategy for it. Instead of making compromises ...